Draft Genome Sequence of the Oral Commensal Streptococcus oralis 89a with Interference Activity against Respiratory Pathogens

Genome Announcements
Hanna E SidjabatAnders Cervin

Abstract

We report the draft genome sequence of the oral commensal Streptococcus oralis 89a isolated from the throat of a healthy child during a streptococcal tonsillitis outbreak in Umeå, Sweden. S. oralis 89a was known to have interference activity against respiratory pathogens in which the colicin V was the potential bacteriocin-encoding gene.

References

Apr 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K RoosS Holm
Jan 1, 1993·International Journal of Pediatric Otorhinolaryngology·K RoosL Lind
Aug 21, 2008·Archives of Disease in Childhood·S SkovbjergA E Wold
May 9, 2009·Microbiology·Thuy DoDavid Beighton
Dec 3, 2013·Nucleic Acids Research·Ross OverbeekRick Stevens

❮ Previous
Next ❯

Citations

Feb 16, 2019·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Claudio AndaloroIgnazio La Mantia

❮ Previous
Next ❯

Datasets Mentioned

BETA
40104
PRJNA297767

Software Mentioned

CLC genomic workbench

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Journal of Gerontological Nursing
V G Pritchard, C S Kerry
Journal of the Royal Army Medical Corps
D L GARDNER
© 2022 Meta ULC. All rights reserved